Clostridium butyricum improves cognitive dysfunction in ICV-STZ-induced Alzheimer’s disease mice via suppressing TLR4 signaling pathway through the gut-brain axis
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0286086 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Yunfang Su und 5 weiteren Autor:innen. Beteiligte Einrichtung: Henan Engineering Research Center for Prevention and Treatment of Major Chronic Diseases with Chinese Medicine, Academy of Chinese Medical Sciences, …. Hauptthemen laut MEDLINE: Alzheimer Disease, Clostridium butyricum, Cognitive Dysfunction. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: research start-up funds, Program for Innovative Research Team (in Science and Technology) in University of Henan Province, ‘liangshan’ research project in Lishui University.
Themen: Demenz
Abstract (Originalsprache)
In recent years, the relationship between gut-brain axis and Alzheimer’s disease (AD) attracted increasing attention. The aim of this study is to investigate the therapeutic effect of Clostridium butyricum (CB) on intraventricular injection of streptozotocin (ICV-STZ)-induced mice and the potential mechanisms. ICV-STZ mice were treated with CB by gavage for 21 consecutive days. The pharmacological effect of CB was assessed by behavior test, brain tissue H&E staining and tau protein phosphorylation levels of hippocampus tissues. The expression levels of TLR4, MYD88, NF-κB p65, TNF-α, iNOS, Occludin and ZO-1 in hippocampal and colonic tissues were detected by Western-blot method. 16S rRNA gene sequencing analysis was used to analyze the intestinal microbiota of mice. The results showed that CB improved the cognitive dysfunction of ICV-STZ mice, restored the structure and cell number of hippocampal and cortical neurons, decreased the protein levels of p Ser404 -tau protein in hippocampal tissues and TLR4, MYD88, NF-κB p65 and iNOS in hippocampal and colonic tissues, and increased the protein levels of Occludin and ZO-1 in colonic tissues. Meanwhile, CB reversed the changes of intestinal microbiota in AD mice. Therefore, the mechanisms of cognitive function and brain pathological changes in AD mice improved by CB may be related to the regulation of TLR4 signaling pathway and intestinal microbiota. This study supports the potential anti-AD effect of CB and initially revealed its pharmacological mechanism of CB, providing a theoretical basis for further clinical application of CB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Henan Engineering Research Center for Prevention and Treatment of Major Chronic Diseases with Chinese Medicine, Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou, Henan Province, China.
- The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan Province, China.
- LiangShan College (LiShui) China, Lishui University, Lishui, Zhejiang Province, China.
- Henan JinBaiHe Biotechnology Co. LTD, Nanjing, Jiangsu, China.
- School of Acupuncture and Massage, Henan University of Chinese Medicine, Zhengzhou, Henan Province, China.
ORCID-Profile: Zhenqiang Zhang
Förderung
- research start-up funds
- Program for Innovative Research Team (in Science and Technology) in University of Henan Province
- ‘liangshan’ research project in Lishui University
Zitieren
APA
Su, Y., Wang, D., Liu, N., Yang, J., Sun, R., & Zhang, Z. (2023). Clostridium butyricum improves cognitive dysfunction in ICV-STZ-induced Alzheimer’s disease mice via suppressing TLR4 signaling pathway through the gut-brain axis. PLOS ONE. https://doi.org/10.1371/journal.pone.0286086
Vancouver
Su Y, Wang D, Liu N, Yang J, Sun R, Zhang Z. Clostridium butyricum improves cognitive dysfunction in ICV-STZ-induced Alzheimer’s disease mice via suppressing TLR4 signaling pathway through the gut-brain axis. PLOS ONE. 2023. doi:10.1371/journal.pone.0286086
BibTeX
@article{Su2023,
author = {Su, Yunfang and Wang, Dahui and Liu, Ningning and Yang, Jiajia and Sun, Ruiqin and Zhang, Zhenqiang},
title = {Clostridium butyricum improves cognitive dysfunction in ICV-STZ-induced Alzheimer’s disease mice via suppressing TLR4 signaling pathway through the gut-brain axis},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0286086}
}
EUVIMED